Disease‐free survival as a predictor of overall survival in localized renal cell carcinoma following initial nephrectomy: A retrospective analysis of Surveillance, Epidemiology and End Results‐Medicare datac. (14th February 2023)

• Record Type: Journal Article
• Authors: Haas, Naomi B.; Song, Yan; Willemann Rogerio, Jaqueline; Zhang, Su; Carley, Christopher; Zhu, JingJing; Bhattacharya, Rituparna; Signorovitch, James; Sundaram, Murali
• Is Part Of: International journal of urology. Volume 30:Number 3(2023)
• Page Start: 272
• Page End: 279
• Publication Date: 2023-02-14
• Subjects: disease‐free survival -- nephrectomy -- overall survival -- recurrence -- renal cell carcinoma; Urology -- Periodicals; Genitourinary organs -- Periodicals; Urologic Diseases -- Periodicals; 616.6005
• DOI: 10.1111/iju.15104
• Languages: English
• ISSNs: 0919-8172

Abstract

Abstract : Objectives: This study aimed to assess whether disease‐free survival (DFS) may serve as a predictor for long‐term survival among patients with intermediate‐high risk or high risk renal cell carcinoma (RCC) post‐nephrectomy when overall survival (OS) is unavailable. Methods: The Surveillance, Epidemiology and End Results‐Medicare database (2007–2016) was used to identify patients with non‐metastatic intermediate‐high risk and high risk RCC post‐nephrectomy. Landmark analysis and Kendall's τ were used to evaluate the correlation between DFS and OS. Multivariable regression models were used to quantify the incremental OS post‐nephrectomy associated with increased time to recurrence among patients with recurrence, adjusting for baseline covariates. Results: A total of 643 patients were analyzed; mean age of 75 years; >95% of patients had intermediate‐high risk RCC at diagnosis; 269 patients had recurrence post‐nephrectomy. For patients with versus without recurrence at the landmark points of 1, 3, and 5 years post‐nephrectomy, the 5‐year OS were 37.0% versus 70.1%, 42.3% versus 72.8%, and 53.2% versus 78.6%, respectively. The Kendall's τ between DFS and OS post‐nephrectomy was 0.70 (95% CI: 0.65, 0.74; p < 0.001). After adjusting for baseline covariates, patients with one additional year of time to recurrence were associated with 0.73 years longer OS post‐nephrectomy (95% CI: 0.40, 1.05; p < 0.001). Conclusion: The significant positive association of DFS and OS among patients with intermediate‐high risk and high risk RCC post‐nephrectomy from this study supports the use of DFS as a potential predictor of OS for these patients when OS data are immature.